Table 1.
No. of patients | (%) | |
---|---|---|
Gender | ||
Male | 50 | |
Female | 33 | |
Age (y) | ||
Median | 65.36 | |
SD | 15.41 | |
T stage | ||
Carcinoma in situ (cis) | 5 | 6.0 |
T1 | 43 | 51.8 |
T2 | 25 | 30.1 |
T3 | 9 | 10.8 |
T4a | 1 | 1.2 |
T4b | 0 | 0.0 |
TNM stage | ||
I | 43 | 51.8 |
II | 18 | 21.7 |
III | 5 | 6.0 |
IVa | 3 | 3.6 |
IVb | 9 | 10.8 |
IVc | 0 | 0.0 |
YK classification | ||
YK ‐1 | 2 | 2.4 |
YK‐2 | 10 | 12.0 |
YK‐3 | 35 | 42.2 |
YK‐4c | 25 | 30.1 |
YK‐4d | 6 | 7.2 |
Differentiation | ||
Well | 42 | 50.6 |
Moderate | 29 | 34.9 |
Poor | 7 | 8.4 |
Local recurrence | 7 | 8.4 |
Cervical lymph node metastasis | 27 | 32.5 |
Distant organ metastasis | 3 | 3.6 |